Enabling CDMOs To Focus On Core Priorities

Several factors contribute to the recent CDMO market segment growth in biopharmaceuticals. To remain competitive, CDMOs must control costs and focus on their core mission of drug development and manufacturing, often achieved by outsourcing pre-production activities to industry experts. This results in greater efficiencies and lower operational costs. Partnering with cGMP chemical suppliers can simplify the drug production process, as they provide pre-weighed and dispensed dry powders and pre-made process liquids/buffers. Companies like Thermo Fisher Scientific offer end-to-end solutions for CDMOs, leading to significant cost savings and improved operational efficiencies. A detailed analysis of the CDMO's pre-manufacturing process can identify bottlenecks and propose solutions, resulting in a more efficient workflow. Providers of complete chemical workflow solutions can further enhance their value by offering comprehensive supply chain support.